71 related articles for article (PubMed ID: 11229338)
41. Silence is golden: gene hypermethylation and survival in large-cell lymphoma.
Dolan ME; Schilsky RL
J Natl Cancer Inst; 2002 Jan; 94(1):6-7. PubMed ID: 11773269
[No Abstract] [Full Text] [Related]
42. [Chlormethine (Caryolysine), carmustine (Bicnu)].
Estève E; Grange F
Ann Dermatol Venereol; 2007 Dec; 134(12):992-6. PubMed ID: 18166924
[No Abstract] [Full Text] [Related]
43. Proper analysis of clinical trials for malignant glioma.
Muir W; Chin HW; Young AB; Maruyama Y
Cancer Treat Rep; 1982 Jan; 66(1):211-3. PubMed ID: 7053262
[No Abstract] [Full Text] [Related]
44. [Targets of antileukemia agents: molecular mechanisms of mercaptopurine action].
Krynetskaia NF; Krynetskiĭ EIu
Mol Biol (Mosk); 2000; 34(6):1046-53. PubMed ID: 11186004
[No Abstract] [Full Text] [Related]
45. Chinese translation of primary glioblastoma.
Leung JS
Hong Kong Med J; 2011 Oct; 17(5):427-8; discussion 428. PubMed ID: 21979488
[No Abstract] [Full Text] [Related]
46. Correction: Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents.
N Engl J Med; 2000 Dec; 343(23):1740. PubMed ID: 11106725
[No Abstract] [Full Text] [Related]
47. O6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: a review of current status.
Suri V; Jha P; Sharma MC; Sarkar C
Neurol India; 2011; 59(2):229-35. PubMed ID: 21483124
[TBL] [Abstract][Full Text] [Related]
48. The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
Buckner JC; Moynihan TJ
N Engl J Med; 2001 Mar; 344(9):686; author reply 687-8. PubMed ID: 11229337
[No Abstract] [Full Text] [Related]
49. The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
Schlegel U
N Engl J Med; 2001 Mar; 344(9):686-7; author reply 687-8. PubMed ID: 11229336
[No Abstract] [Full Text] [Related]
50. The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
Ali-Osman F; Srivenugopal K; Sawaya R
N Engl J Med; 2001 Mar; 344(9):687; author reply 687-8. PubMed ID: 11229339
[No Abstract] [Full Text] [Related]
51. Pharmacogenomics--teaching old drugs new tricks.
Weinstein JN
N Engl J Med; 2000 Nov; 343(19):1408-9. PubMed ID: 11070107
[No Abstract] [Full Text] [Related]
52. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
Esteller M; Garcia-Foncillas J; Andion E; Goodman SN; Hidalgo OF; Vanaclocha V; Baylin SB; Herman JG
N Engl J Med; 2000 Nov; 343(19):1350-4. PubMed ID: 11070098
[TBL] [Abstract][Full Text] [Related]
53. The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
Quinn DI
N Engl J Med; 2001 Mar; 344(9):686; author reply 687-8. PubMed ID: 11229338
[No Abstract] [Full Text] [Related]
54. Targeted modulation of MGMT: clinical implications.
Liu L; Gerson SL
Clin Cancer Res; 2006 Jan; 12(2):328-31. PubMed ID: 16428468
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
